Biogen EBITDA 2006-2019 | BIIB

Biogen annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Biogen EBITDA for the quarter ending December 31, 2019 was $1.891B, a 6.65% increase year-over-year.
  • Biogen EBITDA for the twelve months ending December 31, 2019 was $7.723B, a 11.85% increase year-over-year.
  • Biogen 2019 annual EBITDA was $7.723B, a 11.85% increase from 2018.
  • Biogen 2018 annual EBITDA was $6.905B, a 7.44% increase from 2017.
  • Biogen 2017 annual EBITDA was $6.427B, a 10.15% increase from 2016.
Biogen Annual EBITDA
(Millions of US $)
2019 $7,723
2018 $6,905
2017 $6,427
2016 $5,834
2015 $5,491
2014 $4,661
2013 $3,047
2012 $2,221
2011 $2,084
2010 $1,605
2009 $1,723
2008 $1,676
2007 $1,160
2006 $816
2005 $638
Biogen Quarterly EBITDA
(Millions of US $)
2019-12-31 $1,891
2019-09-30 $2,136
2019-06-30 $2,073
2019-03-31 $1,624
2018-12-31 $1,773
2018-09-30 $2,044
2018-06-30 $1,385
2018-03-31 $1,704
2017-12-31 $1,675
2017-09-30 $1,831
2017-06-30 $1,384
2017-03-31 $1,537
2016-12-31 $1,065
2016-09-30 $1,606
2016-06-30 $1,636
2016-03-31 $1,528
2015-12-31 $1,324
2015-09-30 $1,524
2015-06-30 $1,378
2015-03-31 $1,266
2014-12-31 $1,317
2014-09-30 $1,328
2014-06-30 $1,153
2014-03-31 $862
2013-12-31 $816
2013-09-30 $832
2013-06-30 $791
2013-03-31 $608
2012-12-31 $542
2012-09-30 $629
2012-06-30 $596
2012-03-31 $453
2011-12-31 $498
2011-09-30 $576
2011-06-30 $501
2011-03-31 $509
2010-12-31 $451
2010-09-30 $284
2010-06-30 $483
2010-03-31 $386
2009-12-31 $477
2009-09-30 $470
2009-06-30 $350
2009-03-31 $427
2008-12-31 $447
2008-09-30 $473
2008-06-30 $402
2008-03-31 $353
2007-12-31 $365
2007-09-30 $226
2007-06-30 $299
2007-03-31 $271
2006-12-31 $279
2006-09-30 $287
2006-06-30 $-46
2006-03-31 $296
2005-12-31 $191
2005-09-30 $131
2005-06-30 $145
2005-03-31 $171
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $55.170B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.832B 14.78
Gilead Sciences (GILD) United States $94.414B 12.21
CSL (CSLLY) Australia $89.311B 0.00
Vertex Pharmaceuticals (VRTX) United States $64.729B 58.74
Regeneron Pharmaceuticals (REGN) United States $56.366B 23.87
Illumina (ILMN) United States $41.306B 42.70
Alexion Pharmaceuticals (ALXN) United States $21.890B 10.15
Seattle Genetics (SGEN) United States $20.641B 0.00
Incyte (INCY) United States $19.022B 40.81
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.901B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.322B 612.31
Genmab (GMAB) Denmark $14.121B 10.96
Genmab (GNMSF) Denmark $13.202B 42.46
Galapagos (GLPG) Belgium $13.109B 40.06
Alnylam Pharmaceuticals (ALNY) United States $12.595B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.850B 55.38
Moderna (MRNA) United States $10.666B 0.00
BioNTech SE (BNTX) Germany $10.170B 0.00
Exact Sciences (EXAS) United States $9.821B 0.00
BeiGene (BGNE) Cayman Islands $9.145B 0.00
QIAGEN (QGEN) Netherlands $8.994B 27.42
Sarepta Therapeutics (SRPT) United States $8.079B 0.00
Bio-Techne Corp (TECH) United States $7.632B 52.23
ACADIA Pharmaceuticals (ACAD) United States $6.649B 0.00
Guardant Health (GH) United States $6.091B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.993B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.937B 15.69
Ascendis Pharma (ASND) Denmark $5.823B 0.00
Exelixis (EXEL) United States $5.689B 18.26
Repligen (RGEN) United States $5.026B 91.90
Acceleron Pharma (XLRN) United States $4.588B 0.00
Reata Pharmaceuticals (RETA) United States $4.566B 0.00
China Biologic Products (CBPO) China $4.200B 24.93
Immunomedics (IMMU) United States $3.943B 0.00
Global Blood Therapeutics (GBT) United States $3.791B 0.00
Blueprint Medicines (BPMC) United States $3.621B 0.00
Mirati Therapeutics (MRTX) United States $3.435B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.375B 0.00
MorphoSys AG (MOR) Germany $3.251B 0.00
Emergent Biosolutions (EBS) United States $3.220B 22.36
Zai Lab (ZLAB) China $3.202B 0.00
Vir Biotechnology (VIR) United States $3.195B 0.00
Adaptive Biotechnologies (ADPT) United States $3.162B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.069B 0.00
NeoGenomics (NEO) United States $2.749B 119.18
CRISPR Therapeutics AG (CRSP) Switzerland $2.702B 45.75
Amicus Therapeutics (FOLD) United States $2.580B 0.00
Alkermes (ALKS) Ireland $2.498B 197.88
Deciphera Pharmaceuticals (DCPH) United States $2.478B 0.00
Halozyme Therapeutics (HALO) United States $2.442B 0.00
Arena Pharmaceuticals (ARNA) United States $2.403B 6.26
Bluebird Bio (BLUE) United States $2.394B 0.00
UniQure (QURE) Netherlands $2.391B 0.00
MyoKardia (MYOK) United States $2.336B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.203B 0.00
Amarin (AMRN) Ireland $2.075B 0.00
Principia Biopharma (PRNB) United States $2.028B 0.00
Denali Therapeutics (DNLI) United States $1.968B 0.00
Fate Therapeutics (FATE) United States $1.946B 0.00
Alector (ALEC) United States $1.835B 0.00
Eidos Therapeutics (EIDX) United States $1.805B 0.00
Epizyme (EPZM) United States $1.696B 0.00
Arvinas (ARVN) United States $1.694B 0.00
Zymeworks (ZYME) Canada $1.659B 0.00
Insmed (INSM) United States $1.649B 0.00
Viela Bio (VIE) United States $1.589B 0.00
Akcea Therapeutics (AKCA) United States $1.588B 34.15
Dicerna Pharmaceuticals (DRNA) United States $1.401B 0.00
Ligand Pharmaceuticals (LGND) United States $1.370B 42.57
Inovio Pharmaceuticals (INO) United States $1.214B 0.00
REGENXBIO (RGNX) United States $1.170B 0.00
Coherus BioSciences (CHRS) United States $1.166B 13.82
Zealand Pharma (ZEAL) Denmark $1.157B 0.00
Editas Medicine (EDIT) United States $1.131B 0.00
PHARMA MAR SA (PHMMF) Spain $1.073B 0.00
Myriad Genetics (MYGN) United States $1.063B 18.76
NGM Biopharmaceuticals (NGM) United States $1.019B 0.00
NextCure (NXTC) United States $0.995B 0.00
Twist Bioscience (TWST) United States $0.972B 0.00
Intra-Cellular Therapies (ITCI) United States $0.944B 0.00
Novavax (NVAX) United States $0.885B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.864B 0.00
Beam Therapeutics (BEAM) United States $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.855B 0.00
Sangamo Therapeutics (SGMO) United States $0.811B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.807B 0.00
Cytokineticsorporated (CYTK) United States $0.759B 0.00
I-Mab (IMAB) China $0.747B 0.00
Arcus Biosciences (RCUS) United States $0.704B 0.00
Athenex (ATNX) United States $0.680B 0.00
Retrophin (RTRX) United States $0.674B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Cara Therapeutics (CARA) United States $0.658B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.634B 0.00
Kadmon Holdings (KDMN) United States $0.630B 0.00
GENFIT S.A (GNFT) France $0.624B 0.00
Codexis (CDXS) United States $0.622B 0.00
Mesoblast (MESO) Australia $0.614B 0.00
Intellia Therapeutics (NTLA) United States $0.610B 0.00
Bellus Health (BLU) Canada $0.608B 0.00
Compugen (CGEN) Israel $0.600B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.585B 5.14
ZIOPHARM Oncology Inc (ZIOP) United States $0.564B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.547B 0.00
ANI Pharmaceuticals (ANIP) United States $0.535B 9.64
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.511B 0.00
Clovis Oncology (CLVS) United States $0.509B 0.00
Castle Biosciences (CSTL) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
Athersys (ATHX) United States $0.488B 0.00
Heska (HSKA) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.473B 12.07
Vericel (VCEL) United States $0.467B 69.33
Frequency Therapeutics (FREQ) United States $0.467B 0.00
DBV Technologies S.A (DBVT) France $0.466B 0.00
Verastem (VSTM) United States $0.465B 0.00
Intrexon (PGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Scholar Rock Holding (SRRK) United States $0.452B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.445B 0.00
Sorrento Therapeutics (SRNE) United States $0.444B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Cue Biopharma (CUE) United States $0.441B 0.00
Anika Therapeutics (ANIK) United States $0.438B 15.08
Cel-Sci (CVM) United States $0.432B 0.00
Mersana Therapeutics (MRSN) United States $0.428B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Morphic Holding (MORF) United States $0.418B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.406B 0.00
Cellectis S.A (CLLS) France $0.402B 0.00
MiMedx (MDXG) United States $0.398B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 44.89
CytomX Therapeutics (CTMX) United States $0.383B 0.00
Agenus (AGEN) United States $0.378B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
PDL BioPharma (PDLI) United States $0.361B 10.81
Kala Pharmaceuticals (KALA) United States $0.342B 0.00
Merus (MRUS) Netherlands $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.308B 0.00
Pfenex (PFNX) United States $0.308B 449.50
Puma Biotechnology (PBYI) United States $0.303B 0.00
Cellular Biomedicine (CBMG) United States $0.300B 0.00
Precision BioSciences (DTIL) United States $0.298B 0.00
NantKwest (NK) United States $0.291B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.284B 0.00
Kamada (KMDA) Israel $0.280B 11.65
Syndax Pharmaceuticals (SNDX) United States $0.276B 0.00
Dynavax Technologies (DVAX) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.268B 0.00
Avid Bioservices (CDMO) United States $0.265B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.259B 0.00
Gritstone Oncology (GRTS) United States $0.248B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.246B 0.00
Albireo Pharma (ALBO) United States $0.245B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Seres Therapeutics (MCRB) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
MannKind (MNKD) United States $0.219B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Geron (GERN) United States $0.216B 0.00
Alcobra (ARCT) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Prometic Life Sciences (LMNL) Canada $0.206B 0.00
Abeona Therapeutics (ABEO) United States $0.198B 0.00
Starpharma Holdings (SPHRY) Australia $0.196B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.195B 1.75
XOMA (XOMA) United States $0.190B 0.00
Protagonist Therapeutics (PTGX) United States $0.188B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.178B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
VBI Vaccines (VBIV) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.163B 0.00
OSMOTICA PHARM (OSMT) United States $0.163B 0.00
Exicure (XCUR) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.152B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Fortress Biotech (FBIO) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Affimed (AFMD) Germany $0.149B 0.00
VolitionRX (VNRX) United States $0.148B 0.00
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
Cerecor (CERC) United States $0.139B 0.00
Aytu Bioscience (AYTU) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.132B 0.00
Theratechnologies (THTX) Canada $0.128B 0.00
AIT Therapeutics (XAIR) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.114B 4.47
Enzo Biochem (ENZ) United States $0.113B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Aptinyx (APTX) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.099B 0.00
TELA Bio (TELA) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.097B 2.63
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Five Prime Therapeutics (FPRX) United States $0.089B 0.00
IBio (IBIO) United States $0.089B 0.00
CorMedix Inc (CRMD) United States $0.087B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.079B 0.00
Cyclerion Therapeutics (CYCN) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 4.52
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Eton Pharmaceuticals (ETON) United States $0.076B 0.00
Happiness Biotech Group (HAPP) China $0.076B 0.00
Arbutus Biopharma (ABUS) Canada $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Adocia (ADOCY) France $0.066B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
SESEN BIO, INC (SESN) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.059B 0.00
Synlogic (SYBX) United States $0.057B 0.00
AquaBounty Technologies (AQB) United States $0.055B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Trevena (TRVN) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.047B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.045B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
CollPlant Holdings (CLGN) Israel $0.037B 0.00
Protalix BioTherapeutics (PLX) Israel $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
Celsion (CLSN) United States $0.030B 0.00
Prima BioMed (IMMP) Australia $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Menlo Therapeutics (MNLO) United States $0.026B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00